University Hospital in Toulouse France is conducting a study to assess how platelet function is impacted in adults with ITP over the age of 18 years who have heart disease using 75 mg of aspirin. The goal is also to assess how the use of aspirin among adults with ITP impacts the incidence of arterial thrombosis. Adults with ITP who are using other antiplatelet or anticoagulant drugs will be excluding from participating.
France
https://www.clinicaltrials.gov/ct2/show/NCT04912505?recrs=a&cond=Immune+Thrombocytopenia&draw=2&rank=45
Actively Recruiting